![Norihiko Ishihara](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Norihiko Ishihara
Chief Executive Officer at VLC HOLDINGS CO., LTD.
Net worth: 957 773 $ as of 30/05/2024
Network origin in Norihiko Ishihara first degree
Entity | Entity type | Industry | |
---|---|---|---|
Catalys Pacific LLC
![]() Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands.
12
| Private Company | Investment Managers | 12 |
Public Company | Miscellaneous Commercial Services | 6 | |
MSS Corp.
![]() MSS Corp. Miscellaneous Commercial ServicesCommercial Services Part of VLC HOLDINGS CO., LTD., MSS, Inc. is a Japanese company that engages in marketing research and sales promotional services. The company is based in Tokyo, Japan. MSS, Inc. was founded in 1983.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
VLC Co., Ltd.
![]() VLC Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of VLC HOLDINGS CO., LTD., Bark Co., Ltd. is a consulting service that provides information on marketing research, privacy mark, ISO27001, ISMS acquisition, and operation support IT tools through their official website. The Japanese company also offers consulting services through their official site.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Cybergym Japan Co. Ltd.
2
| Private Company | 2 | |
Strategic Cyber Holdings LLC
1
| Subsidiary | 1 | |
CEL Ltd.
1
| Subsidiary | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Norihiko Ishihara via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Keio University | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Pathalys Pharma, Inc.
![]() Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Pharmaceuticals: Major | Founder Chief Executive Officer Founder | |
VIO Co., Ltd.
![]() VIO Co., Ltd. Information Technology ServicesTechnology Services VIO Co., Ltd. provides value added software solutions. It provides system development and maintenance operational services, application service provider services, hosting services, data connection services, macro creation services, simple email services and contracted development services. The company was founded in April 1977 and is headquartered in Tokyo, Japan. | Information Technology Services | President Director/Board Member | |
TeneoBio, Inc.
![]() TeneoBio, Inc. Miscellaneous Commercial ServicesCommercial Services TeneoBio, Inc. operates as a biotechnology company that develops biologics, human heavy chain antibodies, as therapeutics against cancer, autoimmunity, and infectious diseases. Its products provides treatment of multiple myeloma, prostate cancer, immune disorders, and AIDS. The company was founded by Roland Buelow, on August 9, 2009 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member | |
D2G Oncology, Inc.
![]() D2G Oncology, Inc. Pharmaceuticals: MajorHealth Technology D2G Oncology, Inc. develops relating drugs to genotypes to transform precision cancer therapeutics. The company was founded by Ian Winters and Jonathan MacQuitty in 2018 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Founder | |
Stanford Graduate School of Business | College/University | Masters Business Admin | |
Orca Biosystems, Inc.
![]() Orca Biosystems, Inc. Medical SpecialtiesHealth Technology Orca Biosystems, Inc. engages in empowering cell therapies by precisely engineering bone marrow transplants (BMT) using rapid clinical cell sorting of human grafts. The company was founded by Nathaniel fernhoff and Ivan K. Dimov and is headquartered in Mountain View, CA. | Medical Specialties | Director/Board Member | |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | President | |
Ilypsa, Inc.
![]() Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Chief Executive Officer | |
Freespira, Inc.
![]() Freespira, Inc. Medical SpecialtiesHealth Technology Freespira, Inc. operates as a digital therapeutic company, that focuses on revolutionizing the mental health industry with clinically proven, non-invasive, drug-free solutions. The firm's first commercial product, Freespira, is a treatment for panic attacks and the symptoms of panic disorder. The company was founded in 1987 and is headquartered in Danville, CA. | Medical Specialties | Director/Board Member | |
Centocor, Inc.
![]() Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | President | |
Ortho-McNeil Pharmaceutical LLC
![]() Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
Envisia Therapeutics, Inc.
![]() Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Founder | |
Ortho-mcneil Neurologics, Inc. | President | ||
OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | Director/Board Member | |
NC Life Sciences Organization
![]() NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman | |
LIQUIDIA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
POZEN INC. | Pharmaceuticals: Major | Director/Board Member | |
FORTY SEVEN, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Lightspeed Management Co LLC
![]() Lightspeed Management Co LLC Investment ManagersFinance Lightspeed Management Co. LLC (Lightspeed Venture Partners) is a venture capital firm founded in 1971. The firm is headquartered in Menlo Park, California. It was formerly known as Weiss, Peck & Greer Venture Partners. | Investment Managers | Private Equity Investor | |
Genencor International, Inc.
![]() Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Corporate Officer/Principal | |
University of Sussex | College/University | Doctorate Degree | |
Entelos, Inc.
![]() Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Information Technology Services | Director/Board Member | |
Guava Technologies, Inc.
![]() Guava Technologies, Inc. BiotechnologyHealth Technology Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA. | Biotechnology | Director/Board Member | |
GenPharm International LLC
![]() GenPharm International LLC BiotechnologyHealth Technology GenPharm International, Inc. manufactures biopharmaceutical products. The company works towards the application of transgenic animal technology to the development of human antibody products, which are used for therapeutic uses. It was founded in 1988 and is located in San Jose, CA. | Biotechnology | Chief Executive Officer | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
The North Carolina Biotechnology Center
![]() The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member | |
Abingworth LLP
![]() Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Investor | |
SFJ Pharmaceuticals, Inc.
![]() SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member | |
PERSONALIS, INC. | Medical/Nursing Services | Chairman | |
Gynesonics, Inc.
![]() Gynesonics, Inc. Medical SpecialtiesHealth Technology Gynesonics, Inc. provides medical devices for women's health. It offers VizAblate System for the transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The company was founded by Jessica grossman in 2005 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member | |
Abingworth Management, Inc.
![]() Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Chief Executive Officer | |
EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Director/Board Member | |
COMTURE CORPORATION | Information Technology Services | Director/Board Member | |
Unc Eshelman School of Pharmacy Foundation | Chairman | ||
Global Health Innovative Technology Fund
![]() Global Health Innovative Technology Fund Investment ManagersFinance Global Health Innovative Technology Fund provides funding of scientific research and development for anti-infectives and diagnostics for diseases that affect the developing world. Its activities include facilitation of global research and development partnerships for the discovery and development of new health technologies for the developing world, investment in these global research and development partnerships through a grant-making mechanism and advancement of Japan’s contribution to global health. The company is headquartered in Minato-ku, Japan. | Investment Managers | Corporate Officer/Principal | |
DIAMOND, Inc.
![]() DIAMOND, Inc. Publishing: Books/MagazinesConsumer Services DIAMOND, Inc. engages in publishing business. It handles publication of magazines, books and electronic contents such as CDs and DVDs. It also offers human development support projects and database services. The company was founded in May 1913 and is headquartered in Tokyo, Japan. | Publishing: Books/Magazines | Corporate Officer/Principal | |
AIN HOLDINGS INC. | Drugstore Chains | Director/Board Member | |
HANKYU HANSHIN HOLDINGS, INC. | Other Transportation | Director/Board Member | |
TECHPOINT, INC. | Semiconductors | Director/Board Member | |
Rikkyo University | College/University | Undergraduate Degree | |
Kyoto University | College/University | Doctorate Degree |
Statistics
International
United States | 39 |
Japan | 10 |
United Kingdom | 3 |
Canada | 2 |
Sectoral
Health Technology | 27 |
Consumer Services | 7 |
Technology Services | 5 |
Commercial Services | 5 |
Finance | 5 |
Operational
Director/Board Member | 135 |
President | 22 |
Independent Dir/Board Member | 20 |
Corporate Officer/Principal | 19 |
Chief Executive Officer | 19 |
Most connected contacts
Insiders | |
---|---|
Ryan Drant | 52 |
Jay Shepard | 30 |
Jonathan MacQuitty | 27 |
Neal Fowler | 17 |
Noriko Endo | 11 |
Jon Congleton | 8 |
Nobuo Hanai | 7 |
Takahiro Matsuda | 6 |
Masato Igarashi | 6 |
Go Hirayama | 5 |
Kyoichiro Takahashi | 4 |
Ashwin Ram | 4 |
Masaharu Otake | 4 |
B. T. Slingsby | 3 |
Takeshi Takahashi | 3 |
- Stock Market
- Insiders
- Norihiko Ishihara
- Company connections